Pizotifen


Generic Medicine Info
Administration
May be taken with or without food.
Special Precautions
Patient w/ angle-closure glaucoma, urinary retention, epilepsy. Avoid abrupt withdrawal. Renal and hepatic impairment. Childn. Pregnancy and lactation. Patient Counselling This drug may cause drowsiness, somnolence and dizziness, if affected, do not drive or operate machinery. Monitoring Parameters Monitor hepatic function (prolonged use), wt gain, BP.
Adverse Reactions
Increased appetite, nausea, wt gain, drowsiness, dizziness, dry mouth, fatigue, muscle pain or cramps, heavy or restless legs, fluid retention, facial flushing, reduced libido, exacerbation of epilepsy, dreaming, hepatic injury.
Drug Interactions
Enhances the central effects of sedatives, hypnotics, antihistamines including certain common cold preparations. May reduce the efficacy of cisapride. MAOIs may prolong or intensify the anticholinergic effect of pizotifen.
CIMS Class
Antimigraine Preparations
ATC Classification
N02CX01 - pizotifen ; Belongs to the class of other antimigraine preparations.
Disclaimer: This information is independently developed by CIMS based on pizotifen from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in